Methylene Blue Capsules

Methylene blue is a redox-active cationic dye. In the literature represented here, its practical utility comes from two properties: strong visible colouration at low concentrations, allowing it to be followed by eye through tissue and fluid, and differential affinity for certain cellular and structural components, which forms the basis of staining methods such as the bacterial capsule stain. The capsule stain literature uses it as a counterstain against an unstained capsular background rather than as an agent acting on the organism.

Reported research endpoints are largely observational. Surgical reports have examined methylene blue as an intraoperative visual adjunct for identifying tissue to be debrided in periprosthetic joint infection, and as a marker injected through vascular microcatheters to localise a bleeding segment of small intestine before resection. Anatomical work has used it to compare the spread of injectate between two regional block techniques in human cadavers. Ophthalmic literature documents adverse ocular findings associated with its presence in the anterior segment, including corneal edema, iris discolouration, sterile endophthalmitis and toxic anterior segment syndrome, and anterior capsule staining work has compared it against alternative dyes. An experimental breast reconstruction model examined whether its presence altered capsular contracture outcomes. In materials science, it serves as the standard test adsorbate for evaluating removal efficiency of nanoparticle and biopolymer sorbents.

Methylene blue predates most of the literature cited here, and the candidate references do not document its original synthesis or early development, so that origin is not established by the record available for this page. What the references do show is a long and dispersed history of use as a visual marker across unrelated fields, with reports spanning microbiology staining protocols, urological and ophthalmic surgery, gastrointestinal haemorrhage localisation, and psychiatric study compliance validation.

The more recent record has developed in two directions. Clinical and cadaveric reports have continued to use it for tissue delineation and injectate tracing, while ophthalmic case reports and series have accumulated describing adverse anterior segment findings associated with its intraocular presence. In parallel, environmental and materials chemistry adopted it as a reference dye for characterising adsorbent performance, a use entirely separate from its biological applications.

Published work involving methylene blue falls into three broad frameworks. The first is histological and microbiological staining, where it functions as a counterstain in differential methods. The second is procedural and anatomical marking, including intraoperative tissue delineation, catheter-delivered localisation of bleeding sources, and cadaveric mapping of injectate spread. The third is ophthalmic safety reporting, where case series and case reports describe anterior segment findings associated with its presence in the eye. A further, non-biological literature uses it as a benchmark adsorbate in sorbent and wastewater treatment chemistry.

3 of the 5 areas below are addressed directly by a paper cited on this page.

• 1 × sealed capsule bottle (10mg per capsule / Single Bottle - Pack of 30), batch-labelled
• Batch documentation for the lot shipped, once its certificate is published
• Discreet outer packaging with no product names on the exterior
• Canada Post Xpresspost, tracked, typically 1–2 business days from Canadian stock

• Laboratory consumables of any kind
• Dosing, administration or protocol guidance of any kind